Simplex Trading
LRMR icon

Simplex Trading’s Larimar Therapeutics LRMR Stock Holding History

Simplex Trading’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$841K Buy
186,900
+175,300
+1,511% +$701K ﹤0.01% 2686
2025
Q4 		$44.2K Sell
11,600
-347,000
-97% -$1.35M ﹤0.01% 5765
2025
Q3 		$1.16M Buy
358,600
+28,400
+9% +$106K ﹤0.01% 2912
2025
Q2 		$954K Buy
330,200
+317,400
+2,480% +$735K ﹤0.01% 2829
2025
Q1 		$27K Sell
12,800
-8,300
-39% -$26.2K ﹤0.01% 6333
2024
Q4 		$81K Sell
21,100
-123,000
-85% -$812K ﹤0.01% 5384
2024
Q3 		$943K Sell
144,100
-7,600
-5% -$61.1K ﹤0.01% 2962
2024
Q2 		$1.1M Buy
151,700
+59,900
+65% +$459K ﹤0.01% 2829
2024
Q1 		$696K Buy
91,800
+88,300
+2,523% +$688K ﹤0.01% 3499
2023
Q4 		$15K Buy
+3,500
New +$11.8K ﹤0.01% 7140
2023
Q3 		– Sell
-6,100
Closed -$19K – 9315
2023
Q2 		$19K Buy
+6,100
New +$24.9K ﹤0.01% 6835
2022
Q2 		– Sell
-19,300
Closed -$78K – 10591
2022
Q1 		$78K Buy
+19,300
New +$126K ﹤0.01% 6497
2020
Q3 		– Sell
-33
Closed -$42K – 8163
2020
Q2 		$42K Buy
33
+29
+725% +$338 ﹤0.01% 5642
2020
Q1 		$3K Buy
+4
New +$53 ﹤0.01% 7069
2019
Q1 		– Sell
-1
Closed -$5K – 7512
2018
Q4 		$5K Hold
1
– – ﹤0.01% 6215
2018
Q3 		$7K Hold
1
– – ﹤0.01% 6606
2018
Q2 		$15K Buy
+1
New +$85 ﹤0.01% 6078
2017
Q3 		– Sell
-8
Closed -$11K – 6288
2017
Q2 		$11K Buy
+8
New +$409 ﹤0.01% 3890
2016
Q4 		– Sell
-12
Closed -$3K – 6227
2016
Q3 		$3K Buy
12
+7
+140% +$318 ﹤0.01% 4700
2016
Q2 		$1K Sell
5
-4
-44% -$316 ﹤0.01% 5333
2016
Q1 		$8K Buy
+9
New +$710 ﹤0.01% 3681

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Simplex Trading's LRMR Position: Q1 2026 in Review

Simplex Trading sold out of Larimar Therapeutics (LRMR) in Q1 2026, closing a stake of 30,522 shares — an estimated $122K sold.

Simplex Trading first reported a position in LRMR in Q2 2015 and held it in 27 quarters. The position peaked at $695K in Q3 2025. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Simplex Trading reported no remaining Larimar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 30,522 Larimar Therapeutics shares in Q1 2026, an estimated $122K.
  • Simplex Trading first reported a position in Larimar Therapeutics in Q2 2015 and held it in 27 quarters.
  • Simplex Trading's Larimar Therapeutics position peaked at $695K in Q3 2025.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.